RULMAVI
Live / Registered — Registered (as of 18 Aug 2026)
What this means for you
Registered since 18 Aug 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79449018
- Registration number
- 8397425
- Mark type
- Stylized text
- Filed
- 20 Feb 2026
- Published for opposition
- 30 Jun 2026
- Registered
- 18 Aug 2026
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for prevention and treatment of eye diseases; pharmaceutical preparations for human use for prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for prevention and treatment of kidney diseases; pharmaceutical preparations for human use for prevention and treatment of diabetes; pharmaceutical preparations for human use for prevention and treatment of hypertension; pharmaceutical preparations for human use for prevention and treatment of skin conditions; pharmaceutical preparations for human use in dermatology; pharmaceutical preparations for human use in urology; pharmaceutical preparations for human use in ophthalmology; pharmaceutical preparations for human use for prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for prevention and treatment of allergies; pharmaceutical preparations for human use for prevention and treatment of bone diseases; pharmaceutical preparations for human use for prevention and treatment of respiratory diseases and asthma
Owner
Prosecution history
- 03 Sept 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2026 — PUBLISHED FOR OPPOSITION
- 24 Jun 2026 — NOTICE OF PUBLICATION
- 04 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2026 — ASSIGNED TO EXAMINER
- 20 May 2026 — APPLICATION FILING RECEIPT MAILED
- 20 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 May 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 30 Apr 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB